Nath Bio-Genes (India)
NSE: NATHBIOGEN · ISIN INE448G01010 · Basic Materials
₹137.00−1.25 (−0.90%)
Monday 9 November, 12:29 IST. Delayed. Source: Yahoo Finance.
Price chart
₹137.00 −1.25 (−0.90%) today
The day
- Previous close
- ₹138.25
- Open
- ₹139.63
- Day high
- ₹139.63
- Day low
- ₹135.10
Listed on NSE since 28 January 2014.
Key numbers
- Market value
- ₹263.10 Cr
- P/E (trailing)
- 7.50
- EPS (trailing)
- ₹18.43
- Price to book
- 0.45
- Dividend yield
- 1.46%
- Debt to equity
- 0.20
- Profit margin
- 9.3%
- Beta
- 0.84
- Volume today
- 1,349
- Average volume
- 14,560
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹301.36 Cr | ₹35.01 Cr |
| FY24 | ₹332.62 Cr | ₹39.62 Cr |
| FY25 | ₹364.91 Cr | ₹38.60 Cr |
| FY26 | ₹445.10 Cr | ₹41.63 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | ₹328 Cr | ₹0 | – |
| Q4 FY26Jan–Mar 2026Audited | ₹52 Cr | ₹0 | – |
| Q3 FY26Oct–Dec 2025 | ₹66 Cr | ₹0 | – |
| Q2 FY26Jul–Sep 2025 | ₹44 Cr | ₹0 | – |
| Q1 FY26Apr–Jun 2025 | ₹284 Cr | ₹0 | – |
| Q4 FY25Jan–Mar 2025Audited | ₹52 Cr | ₹0 | – |
Source: Nath Bio-Genes (India)’s results filed with NSE, consolidated (the whole group). Net profit is the share of Nath Bio-Genes (India)’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | March 2026 | September 2025 |
|---|---|---|
| Fixed assets | ₹244 Cr | ₹243 Cr |
| Investments | ₹6 Cr | ₹6 Cr |
| Inventories | ₹451 Cr | ₹308 Cr |
| Owed by customers | ₹85 Cr | ₹179 Cr |
| Cash and equivalents | ₹76 Cr | ₹74.24 L |
| Total assets | ₹1,097 Cr | ₹1,014 Cr |
| Borrowings | ₹139 Cr | ₹155 Cr |
| Total liabilities | ₹417 Cr | ₹334 Cr |
| Shareholders’ equity | ₹680 Cr | ₹680 Cr |
Source: Nath Bio-Genes (India)’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Nath Bio-Genes (India)
Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; fruit seeds, which includes Rustam +, Rustam, Mukhiya, and Ranjit; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; and seeds for vegetables comprising cabbage, French beans, chili, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, coriander, sweet pepper, green peas, pumpkin, and tinda. It also provides plant protection products under the Win-chi-Win, WINPro WinGoli, and WINall brands; and forage seeds under the NUTRIMAX GOLD and NUTRIMAX brand names. The company was founded in 1979 and is based in Mumbai, India.
- Industry
- Agricultural Inputs
- Based in
- Mumbai
- Employees
- 452
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Nath Bio-Genes (India) in the last day or two.
Dividends and corporate actions
All companies- Dividend - Rs 2 Per Share
Dividend · ex-date 11 September 2026
- Dividend - Rs 2 Per Share
Dividend · ex-date 14 August 2025
- Annual General Meeting
Action · ex-date 12 August 2024
- Dividend - Rs 2 Per Share
Dividend · ex-date 9 August 2024
- Extra- Ordinary General Meeting
Action · ex-date 7 March 2024
- Annual General Meeting/Dividend - Rs 2 Per Share
Dividend · ex-date 4 July 2023
- Annual General Meeting/Dividend - Rs 2 Per Share
Dividend · ex-date 23 June 2022
- Annual General Meeting/Dividend - Rs 2 Per Share
Dividend · ex-date 18 August 2021
Source: NSE. Latest first, 8 of 14.
Information only, not investment advice. Prices are delayed.